FDA OFFICES OF SUPPLEMENTAL APPROVALS WOULD BE ESTABLISHED BY AMENDED KASSEBAUM BILL; "MEDGUIDE" WOULD BE BLOCKED BY COATS AMENDMENT
FDA would be required to establish offices of supplemental approval in each of its centers under the version of Sen. Kassebaum's (R-Kan.) FDA reform bill that emerged from committee mark-up March 28. The provision is part of an amendment promoting the submission and approval of NDA supplements that was introduced by Sen. Kennedy (D-Mass.) and approved on a voice vote.
You may also be interested in...
The US Food & Drug Administration is once again proposing a mandatory summary of key labeling information be dispensed with every prescription drug. Will the idea stay on the books this time?
FDA originally proposed mandatory patient labeling in 1980 only to have the rule withdrawn by the incoming Reagan Administration; thirty-five years later, US agency is finalizing a proposed rule on the same topic. Will history repeat itself?
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011